EurekaMag.com logo
+ Site Statistics
References:
47,893,527
Abstracts:
28,296,643
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

TORCH testing in HIV-infected women


, : TORCH testing in HIV-infected women. Clinical Obstetrics and Gynecology 42(1): 149-62; Quiz 174-5

Screening for TORCH (Toxoplasma gondii, rubella, cytomegalovirus and herpes simplex) infections in HIV-infected pregnant women is reviewed. It is recommended that prenatal patients with newly diagnosed HIV infection should be tested for T. gondii IgG antibodies; if positive, IgM antibodies should be obtained in an attempt to rule out acute T. gondii infection.


Accession: 003292397

PMID: 10073308

Submit PDF Full Text: Here


Submit PDF Full Text

No spam - Every submission is manually reviewed

Due to poor quality, we do not accept files from Researchgate

Submitted PDF Full Texts will always be free for everyone
(We only charge for PDFs that we need to acquire)

Select a PDF file:
Close
Close

Related references

Babadjanova, G.S.; Sangilova, U.M., 2001: Estimation of fetus condition in women infected with different TORCH infections. Fetus condition was estimated in 48 pregnant women infected with different TORCH infections and 20 healthy pregnant ones. Serologic investigations, determination of AFP, ultrasonography were performed. Termination of pregnancy was recommended in d...

Klein, R.S.; Flanigan, T.; Schuman, P.; Smith, D.; Vlahov, D., 1999: The effect of immunodeficiency on cutaneous delayed-type hypersensitivity testing in HIV-infected women without anergy: implications for tuberculin testing. HER Study Group. HIV Epidemiology Research. A collaborative study in four urban medical centers in the United States. To determine the effect of human immunodeficiency virus (HIV) infection and immunodeficiency on delayed type hypersensitivity (DTH) responses and the implications for interp...

de Jong, E.P.; Vossen, A.C.T.M.; Walther, F.J.; Lopriore, E., 2013: How to use... neonatal TORCH testing. Toxoplasma gondii, rubella, cytomegalovirus and herpes simplex virus have in common that they can cause congenital (TORCH) infection, leading to fetal and neonatal morbidity and mortality. During the last decades, TORCH screening, which is general...

Siegel, K.; Raveis, V.H.; Gorey, E., 1998: Barriers and pathways to testing among HIV-infected women. Through in-depth interviews the testing experiences of HIV-infected women in New York City were examined. The barriers that impeded the women from recognizing their at-risk status and from seeking testing once their vulnerability was acknowledged...

Karim, R.; Mack, W.J.; Kono, N.; Tien, P.C.; Anastos, K.; Lazar, J.; Young, M.; Cohen, M.; Golub, E.; Greenblatt, R.M.; Kaplan, R.C.; Hodis, H.N., 2013: Gonadotropin and sex steroid levels in HIV-infected premenopausal women and their association with subclinical atherosclerosis in HIV-infected and -uninfected women in the women's interagency HIV study (WIHS). HIV-infected women may experience prolonged amenorrhea, suggesting altered gonadotropin and sex hormone levels. However, the impact of these endocrine disruptions on atherosclerosis has not been evaluated in women living with, or at risk for, HIV...

Paul, A.; Binner, J.G.P.; Vaidhyanathan, B.; Heaton, A.C.J.; Brown, P.M., 2013: Oxyacetylene torch testing and microstructural characterization of tantalum carbide. Tantalum carbide samples have been subjected to high-temperature testing at ∼2300°C using an oxyacetylene torch to evaluate their potential for ultra-high temperature applications. While large samples cracked during the rapid heating, indicatin...

Baranoski, A.S.; Horsburgh, C.Robert.; Cupples, L.Adrienne.; Aschengrau, A.; Stier, E.A., 2012: Risk factors for nonadherence with Pap testing in HIV-infected women. HIV-infected women are at increased risk for cervical cancer; thus, adherence with Papanicolaou (Pap) testing is of particular importance. The objective of this study was to identify risk factors for inadequate Pap testing in a diverse cohort of H...

Ghazi, H.O.; Telmesani, A.M.; Mahomed, M.F., 2002: TORCH agents in pregnant Saudi women. To determine the seroprevalence rates of IgG to common TORCH agents in pregnant Saudi women using indirect enzyme-linked immunosorbent assay. A total of 926 samples of sera were tested for antibodies to TORCH agents known to cause serious congenit...

Luo Lan; Guo Zhi; Feng YuKun et al., 2003: Pet feeding and TORCH infection in pregnant women. In a survey in 1998-2001 the incidence of TORCH infections (toxoplasma, rubella virus, cytomegalovirus, herpes simplex virus and other infections) was investigated in pregnant women who undertook pet feeding and in a control group. The incidence o...

Curry, C.L.; Sage, Y.Hoffman.; Vragovic, O.; Stier, E.A., 2012: Minimally abnormal Pap testing and cervical histology in HIV-infected women. To assess the underlying histology of HIV-infected women with minimally abnormal Pap tests compared to HIV-uninfected women by evaluating their colposcopic and histologic outcomes. Retrospective analysis was performed to identify HIV-infected wome...